US BANCORP \DE\

Bank

Position in RLAY — Relay Therapeutics, Inc.

CIK 36104 MINNEAPOLIS, MN

Position in RLAY

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$98,377

+$46,319 QoQ

Shares Held

5,258

+0.5% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#199

of 256 holders

Holding Since

Mar 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

US BANCORP \DE\ holds $82,066,335 across 213 Biotechnology names. RLAY ranks #62 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AXSM	Axsome Therapeutics, Inc.	66,580	$16,296,786
2	VRTX	Vertex Pharmaceuticals Inc / Ma	32,020	$15,905,293
3	TECH	BIO-TECHNE Corp	137,966	$9,747,297
4	REGN	Regeneron Pharmaceuticals, Inc.	5,330	$3,323,466
5	ARGX	Argenx SE	3,495	$3,242,555
6	ARWR	Arrowhead Pharmaceuticals, Inc.	38,226	$3,115,799
7	JAZZ	Jazz Pharmaceuticals plc	10,103	$2,434,518
8	GMAB	Genmab A/S	88,420	$2,428,896

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$98,377	5,258	+0.5%	Shares	Defined	2026-08-12
2026-03-31	$52,058	5,232	+2.0%	Shares	Defined	2026-05-15
2025-12-31	$43,408	5,131	0.0%	Shares	Defined	2026-01-30
2025-09-30	$26,783	5,131	-6.5%	Shares	Defined	2025-11-12
2025-06-30	$18,978	5,485	+329.5%	Shares	Defined	2025-07-24
2025-03-31	$3,345	1,277	-66.5%	Shares	Defined	2025-05-08
2024-12-31	$15,701	3,811	+257.8%	Shares	Defined	2025-02-05
2024-09-30	$7,540	1,065	-44.1%	Shares	Defined	2024-10-28
2024-06-30	$12,420	1,905	+13.5%	Shares	Defined	2024-08-07
2024-03-31	$13,927	1,678	-8.2%	Shares	Defined	2024-05-08
2023-12-31	$20,126	1,828	+1317.1%	Shares	Defined	2024-02-09
2023-06-30	$1,620	129	+258.3%	Shares	Defined	2023-08-10
2023-03-31	$592	36	-86.5%	Shares	Defined	2023-05-09
2022-09-30	$5,950	266	+13.2%	Shares	Defined	2022-10-27
2022-03-31	$7,033	235	—	Shares	Defined	2022-05-11
No filing history on record for this holder in this stock.